Novo Nordisk announces major expansion of Chartres manufacturing site in France
Novo Nordisk, a global healthcare leader, has announced a significant investment exceeding 16 billion Danish kroner (2.1 billion euros), slated to begin in 2023, to ... Read More
Novo Nordisk commits $2.3bn for expansion of Danish API production plant
Novo Nordisk, a Danish pharmaceutical firm, has declared its intention to funnel DKK 15.9 billion ($2.3 billion) into expanding an existing Active Pharmaceutical Ingredient (API) ... Read More